Use Of Drugs And Polypharmacy In Dyspepsia Patients At UPT. Narumonda Health Center

Article Sidebar

PDF
Published: Nov 28, 2023
DOI: https://doi.org/10.55227/ijhet.v2i4.176
Keywords:
Dyspepsia, Drug use, Polypharmacy

Main Article Content

Andi Josep Nicolas Hutahaean
Program Studi Diploma Tiga Farmasi, Sekolah Tinggi Ilmu Kesehatan (STIKes) Arjuna Laguboti, Jl Y.P Arjuna, Pintubosi, Toba, Sumatera Utara, 22381, Indonesia
Heny Kuriasari
Program Studi Diploma Tiga Farmasi, Sekolah Tinggi Ilmu Kesehatan (STIKes) Arjuna Laguboti, Jl Y.P Arjuna, Pintubosi, Toba, Sumatera Utara, 22381, Indonesia
Rosanto Tamba
Program Studi Sarjana Farmasi, Sekolah Tinggi Ilmu Kesehatan (STIKes) Arjuna Laguboti, Jl Y.P Arjuna, Pintubosi, Toba, Sumatera Utara, 22381, Indonesia
Chrisfani Aritonang
Program Studi Diploma Tiga Farmasi, Sekolah Tinggi Ilmu Kesehatan (STIKes) Arjuna Laguboti, Jl Y.P Arjuna, Pintubosi, Toba, Sumatera Utara, 22381, Indonesia

Abstract

Changes in lifestyle and eating patterns are one of the causes of digestive tract disorders. The most common digestive disorder suffered is dyspepsia. Dyspepsia is a group of clinical symptoms or syndromes consisting of pain, bloating, heat and discomfort in the stomach top. This study aims to determine the description of drug use and polypharmacy in dyspepsia patients at UPT. Narumonda Health Center for the January-April 2023 period based on drug class, type of drug, other types of drug and polypharmacy. This research is a descriptive study with a retrospective approach carried out in June 2023, data obtained from the Patient Visit Book at UPT. Narumonda Community Health Center using total sampling method. The data obtained is presented in the form of frequency tables and diagrams. The research results showed that there were 73 patients from January-April 2023. Based on the antacid drug class (antacid) 73.97%, proton pump inhibitor (Lansoprazole) 63.51%, prokinetic (domperidone) 18.92%, H2 receptor antagonist group (Cetirizine) 61.54%. Based on other drugs, the most widely used is the analgesic group (paracetamol) 36.99%. Minor group polypharmacy 91.89%, major group 8.11%.

Downloads

Download data is not yet available.

Article Details

How to Cite
Andi Josep Nicolas Hutahaean, Heny Kuriasari, Rosanto Tamba, & Chrisfani Aritonang. (2023). Use Of Drugs And Polypharmacy In Dyspepsia Patients At UPT. Narumonda Health Center . International Journal of Health Engineering and Technology, 2(4). https://doi.org/10.55227/ijhet.v2i4.176
Issue
Vol. 2 No. 4 (2023): IJHET NOVEMBER 2023
Section
Health
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

Bertram G. Katzung. (2013). Farmakologi dasar dan klinik (Basic and clinical pharmacology). In 2 (12th ed., p. 652). Buku Kedokteran EGC. http://laser.umm.ac.id/catalog-detail-copy/160002327/

Faridah, U., Hartinah, D., & Farida, N. (2021). Relationship Of Diet With Frequency Of Recurrence Of Dyspepsia In Puskesmas Pamotan Rembang Regency. The 14thUniversity Research Colloqium, 495.

Giringan, F., Prihanto, D., & Ambar, E. (2021). Karakteristik Penderita Dispepsia Di Instalasi Rawat Inap Penyakit Dalam Rumah Sakit Umum Daerah dr Characteristic of dyspepsia patients in the installation of inpatient internal medicine at dr. H. Chasan Boesoirie Regional Hospital. Kieraha Medical Journal, 3(1), 268–5912. https://ejournal.unkhair.ac.id/index.php/kmj

Permatasari, L. (2017). Faktor Risiko, Klasifikasi, dan Terapi Sindrom Dispepsia. Cermin Dunia Kedokteran, 44(12), 870–873.

Pratiwi, Y., & Azzahra, M. K. (2022). Analisis Efektivitas Biaya Berdasarkan Nilai Acer Penggunaan Proton Pump Inhibitor Pada Pasien Dispepsia Di Bangsal Rawat Inap Rsud Ra Kartini Jepara. Cendekia Journal of Pharmacy, 6(1), 89–101. https://doi.org/10.31596/cjp.v6i1.180

Statistik, B. P. (2021). Badan Pusat Statistik. D. S. K. Rakyat.

Sugiyono. (2012). Metode Penelitian Kuantitatif, Kualitatif, dan R&D. Alfabeta.

Suharjono. (2017). Kajian Polifarmasi Dasi Aspek Interaksi, Efektivitas Dan Keamanan Obat. 1–36.

Suri, I., Marvel, M., & Nurmeilis, N. (2021). Gambaran Karakteristik Pasien dan Penggunaan Obat Dispepsia Di Klinik A Daerah Bekasi Timur. Pharmaceutical and Biomedical Sciences Journal (PBSJ), 2(2), 103–109. https://doi.org/10.15408/pbsj.v2i2.19141

Wibawani, E. A. (2019). Faktor-Faktor Yang Berhubungan Dengan Kejadian Dispepsia Pada Pasien Rawat Jalan Poli Penyakit Dalam Di RSUD Koja. Jurnal Kesehatan Komunitas Indonesia, 17(1), 257–266.

Yelvita, F. S. (2022). Profil Penggunaan Obat Pada Pasien Penyakit Dispepsia Rawat Jalan Di Puskesmas Arut Selatan Pangkalan Bun Tahun 2021. הארץ, 8.5.2017, 2003–2005.

Zakiyah, W., Eka Agustin, A., Fauziah, A., Sa’diyyah, N., & Ibnu Mukti, G. (2021). Definisi, Penyebab, Klasifikasi, dan Terapi Sindrom Dispepsia. Jurnal Health Sains, 2(7), 978–985. https://doi.org/10.46799/jhs.v2i7.230